FEBS Letters · 1994 · 99 citations · 15 references
MedicineCell BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingOvarian CancerTumor PromotionAmino AcidsCancer Cell Line ModelsCancer Cell Proliferation InhibitionPlasminogen ActivatorsTumor Cell Invasiveness
A recombinant soluble human urokinase receptor comprising amino acids 1-277 was cloned and transfected into CHO cells. The mutant protein (rec-uPAR277), purified from the CHO cell supernatant by affinity chromatography on immobilized urokinase (uPA), in a four-fold excess, completely abolished the binding of FITC-labeled pro-uPA to the human ovarian cancer cell line, OV-MZ-6. This invasive and tumorigenic cancer cell line expresses uPA, its inhibitor PAI-1, and the high-affinity receptor for uPA, uPAR. Rec-uPAR277 significantly reduced the proliferation of OV-MZ-6 cells in a concentration-dependent manner without altering the viability of the cells. Invasion of OV-MZ-6 cells tested in an in vitro Matrigel invasion assay was inhibited by rec-uPAR277 up to 75%. In conclusion, these results demonstrate that rec-uPAR277 can function as a scavenger for uPA in vitro by inhibiting proliferation and invasion of human cancer cells.
15
Antibodies to plasminogen activator inhibit human tumor metastasis
Liliana Ossowski, E. Reich · Cell · 1983 · 643 citations
Medicine, Cancer Biology, Oncology +12
A.L. Roldan, Maria Vittoria Cubellis, Maria Teresa Masucci et al. · The EMBO Journal · 1990 · 613 citations · Full text
Prevention of metastasis by inhibition of the urokinase receptor.
Craig Crowley, Robert L. Cohen, BK Lucas et al. · Proceedings of the National Academy of Sciences · 1993 · 382 citations
Medicine, Oncology, Pharmacology +9